Fig. 1: Nadir ANC in cycles 1–2 vs PFS weeks—Cox predicted relative hazard values.
From: Early treatment-related neutropenia predicts response to palbociclib

Spearman’s rho = −0.4073 (p < 0.001). HR 1.22 (95% CI 1.13–1.32).
From: Early treatment-related neutropenia predicts response to palbociclib
Spearman’s rho = −0.4073 (p < 0.001). HR 1.22 (95% CI 1.13–1.32).